| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Recursion Pharmaceuticals, Inc. (RXRX) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 26 sells. RXRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.65M | $21.01M | - | |
| Dir | 4.52M | $14.29M | - | |
| CEO | 2.26M | $7.15M | - | |
| Dir | 1.24M | $3.92M | - | |
| Other | 1.11M | $3.50M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2022 | Larson Tina Marriott73 | President And COO | Sale+OE | 16,000 | $10.96 | $175,401.60 | -7.3% | -22.7% | -35.4% | |
| Nov 16, 2022 | Borgeson Blake69 | Director | Sell | 17,770 | $11.12 | $197,609.51 | -0.2% | -26.0% | -40.7% | |
| Nov 15, 2022 | Virani Shafique70 | Chief Business Officer | Sale+OE | 10,000 | $12.31 | $123,122.80 | -5.5% | -32.7% | -39.5% | |
| Nov 3, 2022 | Gibson Christopher70 | Chief Executive Officer | Sale+OE | 39,193 | $10.01 | $392,200.33 | -3.3% | -14.9% | -41.2% | |
| Oct 27, 2022 | Larson Tina Marriott73 | President And COO | Sale+OE | 16,000 | $10.72 | $171,449.60 | -7.2% | -22.4% | -50.1% | |
| Oct 14, 2022 | Virani Shafique70 | Chief Business Officer | Sale+OE | 10,000 | $10.92 | $109,179.50 | -5.2% | -17.0% | -39.2% | |
| Oct 6, 2022 | Gibson Christopher70 | Chief Executive Officer | Sale+OE | 38,553 | $11.58 | $446,573.57 | -3.3% | -33.3% | -40.0% | |
| Sep 29, 2022 | Larson Tina Marriott73 | President And COO | Sale+OE | 16,000 | $10.86 | $173,748.70 | -3.8% | -33.0% | -28.8% | |
| Sep 15, 2022 | Virani Shafique70 | Chief Business Officer | Sale+OE | 10,000 | $13.36 | $133,634.76 | -5.1% | -30.4% | -34.6% | |
| Sep 1, 2022 | Gibson Christopher70 | Chief Executive Officer | Sale+OE | 39,066 | $10.35 | $404,199.05 | -3.4% | -13.6% | -16.2% |